オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/02 | 1,675 | 1,744 | 1,657 | 1,690 | +30 | +1.8% | 710,700 |
2020/06/01 | 1,650 | 1,673 | 1,611 | 1,660 | +12 | +0.7% | 400,600 |
2020/05/29 | 1,650 | 1,681 | 1,626 | 1,648 | -2 | -0.1% | 441,600 |
2020/05/28 | 1,700 | 1,721 | 1,604 | 1,650 | -90 | -5.2% | 1,336,900 |
2020/05/27 | 1,647 | 1,889 | 1,630 | 1,740 | +173 | +11% | 6,046,500 |
2020/05/26 | 1,611 | 1,612 | 1,542 | 1,567 | -47 | -2.9% | 464,400 |
2020/05/25 | 1,662 | 1,673 | 1,606 | 1,614 | -36 | -2.2% | 391,800 |
2020/05/22 | 1,591 | 1,650 | 1,586 | 1,650 | +50 | +3.1% | 513,600 |
2020/05/21 | 1,659 | 1,737 | 1,600 | 1,600 | +10 | +0.6% | 1,243,700 |
2020/05/20 | 1,566 | 1,599 | 1,520 | 1,590 | +40 | +2.6% | 685,200 |
2020/05/19 | 1,490 | 1,594 | 1,451 | 1,550 | +87 | +5.9% | 742,500 |
2020/05/18 | 1,415 | 1,469 | 1,397 | 1,463 | +63 | +4.5% | 278,700 |
2020/05/15 | 1,420 | 1,430 | 1,360 | 1,400 | -4 | -0.3% | 269,600 |
2020/05/14 | 1,433 | 1,476 | 1,392 | 1,404 | -24 | -1.7% | 323,800 |
2020/05/13 | 1,408 | 1,448 | 1,394 | 1,428 | +20 | +1.4% | 305,800 |
2020/05/12 | 1,380 | 1,533 | 1,370 | 1,408 | +38 | +2.8% | 850,900 |
2020/05/11 | 1,381 | 1,400 | 1,330 | 1,370 | -38 | -2.7% | 353,400 |
2020/05/08 | 1,451 | 1,452 | 1,376 | 1,408 | -17 | -1.2% | 372,900 |
2020/05/07 | 1,351 | 1,447 | 1,351 | 1,425 | +47 | +3.4% | 391,500 |
2020/05/01 | 1,341 | 1,388 | 1,312 | 1,378 | +23 | +1.7% | 287,900 |
2020/04/30 | 1,383 | 1,406 | 1,352 | 1,355 | -12 | -0.9% | 354,600 |
2020/04/28 | 1,317 | 1,378 | 1,314 | 1,367 | +42 | +3.2% | 230,100 |
2020/04/27 | 1,299 | 1,339 | 1,278 | 1,325 | +40 | +3.1% | 215,400 |
2020/04/24 | 1,330 | 1,330 | 1,279 | 1,285 | -29 | -2.2% | 248,400 |
2020/04/23 | 1,288 | 1,317 | 1,273 | 1,314 | +47 | +3.7% | 240,400 |
2020/04/22 | 1,340 | 1,340 | 1,264 | 1,267 | -81 | -6% | 355,200 |
2020/04/21 | 1,387 | 1,420 | 1,327 | 1,348 | -9 | -0.7% | 366,300 |
2020/04/20 | 1,332 | 1,376 | 1,332 | 1,357 | +12 | +0.9% | 156,900 |
2020/04/17 | 1,357 | 1,370 | 1,326 | 1,345 | -12 | -0.9% | 221,300 |
2020/04/16 | 1,361 | 1,369 | 1,327 | 1,357 | -13 | -0.9% | 157,100 |
2020/04/15 | 1,371 | 1,401 | 1,357 | 1,370 | -15 | -1.1% | 221,900 |
2020/04/14 | 1,344 | 1,415 | 1,336 | 1,385 | +65 | +4.9% | 426,600 |
2020/04/13 | 1,310 | 1,361 | 1,290 | 1,320 | -3 | -0.2% | 238,400 |
2020/04/10 | 1,350 | 1,374 | 1,295 | 1,323 | -34 | -2.5% | 248,900 |
2020/04/09 | 1,271 | 1,374 | 1,261 | 1,357 | +91 | +7.2% | 420,500 |
2020/04/08 | 1,256 | 1,278 | 1,219 | 1,266 | +9 | +0.7% | 205,500 |
2020/04/07 | 1,250 | 1,299 | 1,216 | 1,257 | +42 | +3.5% | 336,500 |
2020/04/06 | 1,168 | 1,237 | 1,160 | 1,215 | +38 | +3.2% | 341,800 |
2020/04/03 | 1,280 | 1,286 | 1,159 | 1,177 | -73 | -5.8% | 441,600 |
2020/04/02 | 1,231 | 1,285 | 1,224 | 1,250 | +8 | +0.6% | 270,900 |
2020/04/01 | 1,300 | 1,313 | 1,231 | 1,242 | -70 | -5.3% | 337,200 |
2020/03/31 | 1,370 | 1,386 | 1,307 | 1,312 | +17 | +1.3% | 376,900 |
2020/03/30 | 1,260 | 1,329 | 1,258 | 1,295 | -9 | -0.7% | 320,800 |
2020/03/27 | 1,375 | 1,394 | 1,286 | 1,304 | -56 | -4.1% | 599,100 |
2020/03/26 | 1,429 | 1,462 | 1,324 | 1,360 | -77 | -5.4% | 502,200 |
2020/03/25 | 1,448 | 1,505 | 1,409 | 1,437 | +19 | +1.3% | 702,900 |
2020/03/24 | 1,449 | 1,459 | 1,392 | 1,418 | +20 | +1.4% | 543,900 |
2020/03/23 | 1,371 | 1,430 | 1,341 | 1,398 | +1 | +0.1% | 388,300 |
2020/03/19 | 1,408 | 1,408 | 1,310 | 1,397 | +64 | +4.8% | 413,100 |
2020/03/18 | 1,417 | 1,482 | 1,313 | 1,333 | -54 | -3.9% | 650,400 |
1101~
1150
件表示中 / 2681件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 67,400円 | +58.7% | - | 0.00% | - | 11.88倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
大幸薬品 | 36,200円 | +11.1% | - | 0.00% | 33.03倍 | 2.25倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
ヘリオス | 20,000円 | +395.9% | - | 0.00% | - | 5.55倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ステラファーマ | 51,400円 | +245.7% | - | 0.00% | - | 5.68倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
CANBAS | 92,100円 | - | - | 0.00% | - | 7.64倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム